Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 2/20 | 0.43 |
| ▸ | F3 | P13726 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | TOP1 | P11387 | 3/20 | 0.42 |
| ▸ | FAAH | O00519 | 4/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | TERT | O14746 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | FABP4 | P15090 | 2/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.39 |
| ▸ | PPARG | P37231 | 2/20 | 0.39 |
| ▸ | PPARD | Q03181 | 2/20 | 0.39 |
| ▸ | PPARA | Q07869 | 2/20 | 0.39 |
| ▸ | SQLE | Q14534 | 2/20 | 0.39 |
| ▸ | GMNN | O75496 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6975650 | 1.00 | F7 (0.43) | F7F3KMT2ATOP1FAAH | |
| SCHEMBL7288000 | 0.91 | TOP1 (0.53) | F7F3KMT2ATOP1FAAH | |
| SCHEMBL7286020 | 0.84 | KMT2A (0.46) | KMT2AMAPTSQLEALOX15ATM | |
| SCHEMBL57502 | 0.84 | — | — | |
| SCHEMBL957232 | 0.84 | — | — | |
| SCHEMBL7278067 | 0.83 | PPARG (0.44) | F7F3KMT2ATRPV1MAPT | |
| SCHEMBL27154643 | 0.83 | TRPV1 (0.48) | F7F3KMT2ATOP1FAAH | |
| SCHEMBL31135128 | 0.81 | FAAH (0.52) | F7F3KMT2ATOP1FAAH | |
| SCHEMBL31135057 | 0.81 | FAAH (0.52) | F7F3KMT2ATOP1FAAH | |
| SCHEMBL25214228 | 0.81 | FAAH (0.52) | F7F3KMT2ATOP1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9879292-B2 | Apparatus and methods for biosynthetic production of cannabinoids | Teewinot Technologies, Ltd. (IE) | 2018-01-30 | — | — | US | disclosed |
| US-20170233778-A1 | APPARATUS AND METHODS FOR BIOSYNTHETIC PRODUCTION OF CANNABINOIDS | FULL SPECTRUM LABORATORIES LIMITED (IE) | 2017-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170233778-A1 | APPARATUS AND METHODS FOR BIOSYNTHETIC PRODUCTION OF CANNABINOIDS | COASY, CNR1, CNR2 | F7 872/4885F3 3429/4885KMT2A 1341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.